{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:20:10Z","timestamp":1791822010663,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021LZXNYD-Z09"],"award-info":[{"award-number":["2021LZXNYD-Z09"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023SYF106"],"award-info":[{"award-number":["2023SYF106"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022-JYJ-154"],"award-info":[{"award-number":["2022-JYJ-154"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2024MS515"],"award-info":[{"award-number":["2024MS515"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC2101"],"award-info":[{"award-number":["2024NSFSC2101"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A Research Project on the Integration of Traditional Chinese and Western Medicine Conducted at Southwest Medical University","award":["2024ZXYZX06"],"award-info":[{"award-number":["2024ZXYZX06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06155-5","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T22:33:16Z","timestamp":1739831596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["IFN-\u03b3-mediated inhibition of JAK\/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-8808","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"6155_CR1","doi-asserted-by":"publisher","first-page":"22232","DOI":"10.1038\/s41598-024-72795-0","volume":"14","author":"Z Yang","year":"2024","unstructured":"Yang Z, Li A, Jiang Y, Maidaiti X, Wu Y, Jin Y. Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021. Sci Rep. 2024;14:22232.","journal-title":"Sci Rep"},{"key":"6155_CR2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, George J. MAFLD: how is it different from NAFLD? Clin Mol Hepatol. 2023;29:S17\u201331.","journal-title":"Clin Mol Hepatol"},{"key":"6155_CR3","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73:691\u2013702.","journal-title":"Gut"},{"key":"6155_CR4","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","volume":"80","author":"A De","year":"2024","unstructured":"De A, Bhagat N, Mehta M, Taneja S, Duseja A. Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD. J Hepatol. 2024;80:e61\u20132.","journal-title":"J Hepatol"},{"key":"6155_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"6155_CR6","doi-asserted-by":"publisher","first-page":"154626","DOI":"10.1016\/j.phymed.2022.154626","volume":"110","author":"C Chen","year":"2023","unstructured":"Chen C, Chen J, Wang Y, Fang L, Guo C, Sang T, Peng H, Zhao Q, Chen S, Lin X, Wang X. Ganoderma Lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-\u03b2\/Smad signaling. Phytomedicine. 2023;110:154626.","journal-title":"Phytomedicine"},{"key":"6155_CR7","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, Cai S, Fang L. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway. Cell Prolif. 2022;55:e13158.","journal-title":"Cell Prolif"},{"key":"6155_CR8","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.mam.2023.101231","volume":"95","author":"M Parola","year":"2024","unstructured":"Parola M, Pinzani M. Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies. Mol Aspects Med. 2024;95:101231.","journal-title":"Mol Aspects Med"},{"key":"6155_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41419-019-2101-4","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Chen B, Dong W, Kong M, Fan Z, Yu L, Wu D, Lu J, Xu Y. MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription. Cell Death Dis. 2019;10:899.","journal-title":"Cell Death Dis"},{"key":"6155_CR10","first-page":"735","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lu T, Zhang C, Xue Z, Busuttil R, Kupiec-Weglinski J, Ji H. Activation of YAP attenuates hepatic damage and fibrosis in Liver Ischemia-Reperfusion Injury: from bench to Bedside. Am J Transplant. 2020;20:735\u2013735.","journal-title":"Am J Transplant"},{"key":"6155_CR11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere JP, Schwabe RF. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"key":"6155_CR12","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776\u201384.","journal-title":"J Clin Invest"},{"key":"6155_CR13","doi-asserted-by":"crossref","unstructured":"Piera-Velazquez S, Mendoza FA, Jimenez SA. Endothelial to mesenchymal transition (EndoMT) in the Pathogenesis of Human Fibrotic diseases. J Clin Med 2016, 5.","DOI":"10.3390\/jcm5040045"},{"key":"6155_CR14","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.ymthe.2018.05.002","volume":"26","author":"V Miscianinov","year":"2018","unstructured":"Miscianinov V, Martello A, Rose L, Parish E, Cathcart B, Mitic T, Gray GA, Meloni M, Al Haj Zen A, Caporali A. MicroRNA-148b targets the TGF-beta pathway to regulate angiogenesis and endothelial-to-mesenchymal transition during skin Wound Healing. Mol Ther. 2018;26:1996\u20132007.","journal-title":"Mol Ther"},{"key":"6155_CR15","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1038\/ncomms11853","volume":"7","author":"SM Evrard","year":"2016","unstructured":"Evrard SM, Lecce L, Michelis KC, Nomura-Kitabayashi A, Pandey G, Purushothaman KR, d\u2019Escamard V, Li JR, Hadri L, Fujitani K, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016;7:11853.","journal-title":"Nat Commun"},{"key":"6155_CR16","doi-asserted-by":"publisher","first-page":"14710","DOI":"10.1038\/ncomms14710","volume":"8","author":"SM Evrard","year":"2017","unstructured":"Evrard SM, Lecce L, Michelis KC, Nomura-Kitabayashi A, Pandey G, Purushothaman KR, d\u2019Escamard V, Li JR, Hadri L, Fujitani K, et al. Corrigendum: endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2017;8:14710.","journal-title":"Nat Commun"},{"key":"6155_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41423-022-00966-y","volume":"20","author":"Q Song","year":"2023","unstructured":"Song Q, Datta S, Liang X, Xu X, Pavicic P, Zhang X, Zhao Y, Liu S, Zhao J, Xu Y, et al. Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization. Cell Mol Immunol. 2023;20:143\u201357.","journal-title":"Cell Mol Immunol"},{"key":"6155_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.20826","volume":"42","author":"Z Li","year":"2005","unstructured":"Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005;42:880\u20135.","journal-title":"Hepatology"},{"key":"6155_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/hep.21221","volume":"44","author":"M Kremer","year":"2006","unstructured":"Kremer M, Hines IN, Milton RJ, Wheeler MD. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology. 2006;44:216\u201327.","journal-title":"Hepatology"},{"key":"6155_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cyto.2008.07.001","volume":"44","author":"ML Olleros","year":"2008","unstructured":"Olleros ML, Martin ML, Vesin D, Fotio AL, Santiago-Raber ML, Rubbia-Brandt L, Spahr L, Hadengue A, Garcia I. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines. Cytokine. 2008;44:118\u201325.","journal-title":"Cytokine"},{"key":"6155_CR21","doi-asserted-by":"publisher","first-page":"154519","DOI":"10.1016\/j.cyto.2018.08.013","volume":"124","author":"M M\u00f8hlenberg","year":"2019","unstructured":"M\u00f8hlenberg M, Terczynska-Dyla E, Thomsen KL, George J, Eslam M, Gr\u00f8nb\u00e6k H, Hartmann R. The role of IFN in the development of NAFLD and NASH. Cytokine. 2019;124:154519.","journal-title":"Cytokine"},{"key":"6155_CR22","unstructured":"Wang Q, Bu Q, Xu Z, Liang Y, Zhou J, Pan Y, Zhou H, Lu L. Macrophage ATG16L1 expression suppresses MASH progression by promoting lipophagy. Clin Mol Hepatol 2024."},{"key":"6155_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2022.03.006","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang X, Yao Y, Hou X, Wei L, Rao Y, Su Y, Zheng G, Ruan XZ, Li D, Chen Y. Macrophage SCAP contributes to metaflammation and lean NAFLD by activating STING-NF-\u03baB signaling pathway. Cell Mol Gastroenterol Hepatol. 2022;14:1\u201326.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6155_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, Hartmann D, H\u00fcser N, Meiser P, Bayerl F, et al. Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592:444\u20139.","journal-title":"Nature"},{"key":"6155_CR25","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","volume":"22","author":"H Yao","year":"2016","unstructured":"Yao H, Qiao YJ, Zhao YL, Tao XF, Xu LN, Yin LH, Qi Y, Peng JY. Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22:6890\u2013905.","journal-title":"World J Gastroenterol"},{"key":"6155_CR26","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1111\/bph.15913","volume":"179","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tan L, Jiao K, Xue C, Tang Q, Jiang S, Ren Y, Chen H, El-Aziz TMA, Abdelazeem KNM, et al. Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels. Br J Pharmacol. 2022;179:4792\u2013808.","journal-title":"Br J Pharmacol"},{"key":"6155_CR27","doi-asserted-by":"crossref","unstructured":"Park MY, Ha SE, Kim HH, Bhosale PB, Abusaliya A, Jeong SH, Park JS, Heo JD, Kim GS. Scutellarein inhibits LPS-Induced inflammation through NF-\u03baB\/MAPKs signaling pathway in RAW264.7 cells. Molecules 2022, 27.","DOI":"10.3390\/molecules27123782"},{"key":"6155_CR28","doi-asserted-by":"publisher","first-page":"108193","DOI":"10.1016\/j.intimp.2021.108193","volume":"101","author":"D Liu","year":"2021","unstructured":"Liu D, Zhang C, Hu M, Su K. Scutellarein relieves the death and inflammation of tubular epithelial cells in ischemic kidney injury by degradation of COX-2 protein. Int Immunopharmacol. 2021;101:108193.","journal-title":"Int Immunopharmacol"},{"key":"6155_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/10715762.2017.1422602","volume":"52","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ji R, Sun H, Peng J, Ma X, Wang C, Fu Y, Bao L, Jin Y. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPAR\u03b3\/PGC-1\u03b1-Nrf2 pathway. Free Radic Res. 2018;52:198\u2013211.","journal-title":"Free Radic Res"},{"key":"6155_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.14218\/JCTH.2022.00067","volume":"10","author":"K Clare","year":"2022","unstructured":"Clare K, Dillon JF, Brennan PN. Reactive oxygen species and oxidative stress in the pathogenesis of MAFLD. J Clin Transl Hepatol. 2022;10:939\u201346.","journal-title":"J Clin Transl Hepatol"},{"key":"6155_CR31","doi-asserted-by":"crossref","unstructured":"Ha SE, Kim SM, Vetrivel P, Kim HH, Bhosale PB, Heo JD, Lee HJ, Kim GS. Inhibition of cell proliferation and metastasis by Scutellarein regulating PI3K\/Akt\/NF-\u03baB signaling through PTEN Activation in Hepatocellular Carcinoma. Int J Mol Sci 2021, 22.","DOI":"10.3390\/ijms22168841"},{"key":"6155_CR32","doi-asserted-by":"publisher","first-page":"113187","DOI":"10.1016\/j.biopha.2022.113187","volume":"151","author":"S Chen","year":"2022","unstructured":"Chen S, Li R, Chen Y, Chou CK, Zhang Z, Yang Y, Liao P, Wang Q, Chen X. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells. Biomed Pharmacother. 2022;151:113187.","journal-title":"Biomed Pharmacother"},{"key":"6155_CR33","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1038\/s41598-023-33156-5","volume":"13","author":"QY Jia","year":"2023","unstructured":"Jia QY, Chen HL, Qi Z, Zhang XL, Zheng LY, Liu TT, Yuan Y, Yang L, Wu CY. Network pharmacology to explore the mechanism of scutellarin in the treatment of brain ischaemia and experimental verification of JAK2\/STAT3 signalling pathway. Sci Rep. 2023;13:7557.","journal-title":"Sci Rep"},{"key":"6155_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/13880209.2020.1779318","volume":"58","author":"M Xu","year":"2020","unstructured":"Xu M, Li X, Song L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia\/reperfusion injury via inhibiting JAK\/STAT pathway. Pharm Biol. 2020;58:655\u201363.","journal-title":"Pharm Biol"},{"key":"6155_CR35","doi-asserted-by":"crossref","unstructured":"Hart KM, Fabre T, Sciurba JC, Gieseck RL 3rd, Borthwick LA, Vannella KM, Acciani TH, de Queiroz Prado R, Thompson RW, White S et al. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-\u03b2. Sci Transl Med 2017, 9.","DOI":"10.1126\/scitranslmed.aal3694"},{"key":"6155_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375\u201386.","journal-title":"Nat Rev Immunol"},{"key":"6155_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402.","journal-title":"Signal Transduct Target Ther"},{"key":"6155_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","volume":"25","author":"FS Younesi","year":"2024","unstructured":"Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024;25:617\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6155_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41467-017-01169-0","volume":"8","author":"NP Dufton","year":"2017","unstructured":"Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A, Webb G, Yang Y, Birdsey GM, Lalor P, et al. Dynamic regulation of canonical TGF\u03b2 signalling by endothelial transcription factor ERG protects from liver fibrogenesis. Nat Commun. 2017;8:895.","journal-title":"Nat Commun"},{"key":"6155_CR40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","volume":"124","author":"J Bischoff","year":"2019","unstructured":"Bischoff J. Endothelial-to-mesenchymal transition. Circ Res. 2019;124:1163\u20135.","journal-title":"Circ Res"},{"key":"6155_CR41","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 2011;179:1074\u201380.","journal-title":"Am J Pathol"},{"key":"6155_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvx253","volume":"114","author":"C Souilhol","year":"2018","unstructured":"Souilhol C, Harmsen MC, Evans PC, Krenning G. Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018;114:565\u201377.","journal-title":"Cardiovasc Res"},{"key":"6155_CR43","doi-asserted-by":"publisher","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","volume":"305","author":"XY Luo","year":"2013","unstructured":"Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK. IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Am J Physiol Gastrointest Liver Physiol. 2013;305:G891\u2013899.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6155_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s43018-020-0038-2","volume":"1","author":"R Thibaut","year":"2020","unstructured":"Thibaut R, Bost P, Milo I, Cazaux M, Lema\u00eetre F, Garcia Z, Amit I, Breart B, Cornuot C, Schwikowski B, Bousso P. Bystander IFN-\u03b3 activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nat Cancer. 2020;1:302\u201314.","journal-title":"Nat Cancer"},{"key":"6155_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2021.03.005","volume":"134","author":"J Li","year":"2021","unstructured":"Li J, Chen Q, Yi J, Lan X, Lu K, Du X, Guo Z, Guo Y, Geng M, Li D, Lu S. IFN-\u03b3 contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1\u03b2\/TLR2 signaling pathway. Mol Immunol. 2021;134:118\u201328.","journal-title":"Mol Immunol"},{"key":"6155_CR46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","volume":"64","author":"C Schindler","year":"1995","unstructured":"Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995;64:621\u201351.","journal-title":"Annu Rev Biochem"},{"key":"6155_CR47","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","volume":"175","author":"M Grohmann","year":"2018","unstructured":"Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, Rasmiena AA, Kaur S, Gulati T, Goh PK, et al. Obesity drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289\u2013e13061220.","journal-title":"Cell"},{"key":"6155_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbrc.2015.08.104","volume":"466","author":"J Ahn","year":"2015","unstructured":"Ahn J, Lee J, Kim S. Interferon-gamma inhibits the neuronal differentiation of neural progenitor cells by inhibiting the expression of Neurogenin2 via the JAK\/STAT1 pathway. Biochem Biophys Res Commun. 2015;466:52\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"6155_CR49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6155_CR50","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2174\/1381612822666160125114900","volume":"22","author":"A Loureiro","year":"2016","unstructured":"Loureiro A, Azoia NG, Gomes AC, Cavaco-Paulo A. Albumin-based Nanodevices as Drug Carriers. Curr Pharm Des. 2016;22:1371\u201390.","journal-title":"Curr Pharm Des"},{"key":"6155_CR51","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2147\/DDDT.S299479","volume":"15","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen S, Yang X, Zhang S, Cui C. Preparation optimization of bovine serum albumin nanoparticles and its application for siRNA delivery. Drug Des Devel Ther. 2021;15:1531\u201347.","journal-title":"Drug Des Devel Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06155-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T22:33:23Z","timestamp":1739831603000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06155-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6155"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06155-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol involving mice was formally approved by the Animal Care and Use Committee of Southwest Medical University to ensure strict adherence to the highest ethical principles and regulatory guidelines. The use of human liver samples was authorized by the Ethical Review Committee of the Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, ensuring strict adherence to all ethical principles and guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the manuscript and gave their consent for submission and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"195"}}